bonyf NV / Key word (s): Product Launch/Patent bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne 13-March-2025 / 13:45 ...
Most inventors and innovators rightfully assume that getting a patent is a years-long process. But what if you could secure ...
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent ...
Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed on its ...
Nasdaq-listed AI mobility tech leader secures key intellectual property for computer vision-based driver risk assessment methodNEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ...
BioCardia believes its Helix System to be the only catheter-based intramyocardial delivery system in active clinical use. BioCardia has secured an extensive portfolio of issued patents and pending ...
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
Sperry Rand was finally granted a patent for the first logic system or basic system of its electronic computer. Now the company must decide whether to sue other computer makers who use the same ...
Our latest patent-pending innovation brings the proven security ... they are truly applicable and available to virtually all industries that use any type of technical specifications, like ...
Freshfields represented Moderna, while Taylor Wessing advised BioNTech and Munich IP-firm df-mp was counsel to Pfizer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback